Shawn D. Hingtgen

Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases.

Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Neural stem cell therapy for cancer.

Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.

Fibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.

Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.

Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma.

Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.

Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.

Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.

Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.